Association of Cytomegalovirus Disease and Acute Rejection with Graft Loss in Kidney Transplantation

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Transplantation

• Publication date

  2004-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.TP.0000137105.92464.F3PMID 15480171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytomegalovirus infection and graft rejection in renal transplantation: a single-center experience.

  2003cited by this paper
• Significance of cytomegalovirus infection in renal transplantation.

  2003cited by this paper
• The Impact of Cytomegalovirus Infection and Disease on Rejection Episodes in Renal Allograft Recipients

  2002cited by this paper
• Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.

  2002cited by this paper
• The use of antimicrobial drugs in transplant patients.

  2001cited by this paper
• Cytomegalovirus in solid organ transplantation

  2001cited by this paper
• CYTOMEGALOVIRUS INFECTION AND GRAFT REJECTION IN RENAL TRANSPLANTATION

  2001influential reference
• INCREASED IMPACT OF ACUTE REJECTION ON CHRONIC ALLOGRAFT FAILURE IN RECENT ERA

  2000influential reference
• Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses

  2000cited by this paper
• Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem.

  1999cited by this paper
• Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

  1999cited by this paper
• Expression of granzyme B during primary cytomegalovirus infection after renal transplantation.

  1999cited by this paper
• Quantitative assessment of the first acute rejection as a predictor of renal transplant outcome.

  1999cited by this paper
• [Cytomegalovirus infection, a risk factor for acute graft rejection in renal transplant recipients. A case-controlled study].

  1999cited by this paper
• CMV infection and disease in kidney and pancreas transplant recipients.

  1999cited by this paper
• Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients.

  1999cited by this paper
• Infection in organ-transplant recipients.

  1998influential reference
• Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis.

  1998cited by this paper
• Infection in organ-transplant recipients.

  1998cited by this paper
• Modelling time-dependent interaction in a time-varying covariate and its application to rejection episodes and kidney transplant failure.

  1998cited by this paper
• Long-term renal allograft survival: prognostic implication of the timing of acute rejection episodes.

  1997cited by this paper
• De novo immunotactoid glomerulopathy of the renal allograft: possible association with cytomegalovirus infection.

  1994cited by this paper
• New developments in cytomegalovirus prevention and management.

  1993cited by this paper
• Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients.

  1993cited by this paper
• Risk factors for chronic rejection in renal allograft recipients.

  1993cited by this paper
• Impact of cytomegalovirus infection on organ transplant recipients.

  1990influential reference

• Human Cytomegalovirus Infection Induces Long‐Term Changes in the Cytokine Milieu of Kidney Transplant Recipients

  2025cites this paper
• Efficacy and Safety of Mycophenolate Mofetil In De Novo Renal Transplantation in a Retrospective Cohort of Transplant Recipients in Colombia-Esmitren Study.

  2024cites this paper
• The Impact of ABCC2 -24C>T Gene Polymorphism on Graft Survival in Kidney Transplant Recipients

  2024cites this paper
• Acquisition of Antibody Against Cytomegalovirus After Kidney Transplantation in Seronegative Recipients.

  2023cites this paper
• Risk of Cytomegalovirus Infection and Subsequent Allograft Failure after Pancreas Transplantation.

  2023cites this paper
• Recurrent Cytomegalovirus Infection Controlled by the Introduction of Everolimus in a Simultaneous Pancreas-Kidney Transplantation Recipient: A Case Report.

  2022cites this paper
• Serodetection of Cytomegalovirus and Epstein - Barr virus Antibodies Among Hemodialysis Patients

  2022cites this paper
• A machine learning framework for predicting long-term graft survival after kidney transplantation

  2021cites this paper
• Associations of high anti-CMV IgG titer with renal function decline and allograft rejection in kidney transplant patients

  2021cites this paper
• EBV, CMV, and BK viral infections in pediatric kidney transplantation: Frequency, risk factors, treatment, and outcomes

  2021cites this paper
• Cytomegalovirus Viremia and Risk Factors in Renal Transplant Recipients in Iran: a Prospective Case-control Study

  2021cites this paper
• Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6‐month trimethoprim‐sulfamethoxazole prophylaxis: A case‐control study

  2020cites this paper
• Clinical consequences of primary CMV infection after renal transplantation: a case–control study

  2020cites this paper
• Population Pharmacokinetics and Bayesian Estimation of the Area Under the Concentration‐Time Curve for Ganciclovir in Adult Chinese Renal Allograft Recipients After Valganciclovir Administration

  2020cites this paper
• A Comprehensive Evaluation of Risk Factors for Pneumocystis jirovecii Pneumonia in Adult Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis

  2020cites this paper
• Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response

  2020cites this paper
• Relationship between early proteinuria and long term outcome of kidney transplanted patients from different decades of donor age

  2019cites this paper
• The Role of Suppressor of Cytokine Signaling 1 and 3 in Human Cytomegalovirus Replication

  2019cites this paper
• Limited sampling strategy for the estimation of the area under the concentration-time curve for ganciclovir in Chinese adult renal allograft recipients

  2019cites this paper
• Face Transplantation for Granulomatosis With Polyangiitis (Wegener Granulomatosis): Technical Considerations, Immunological Aspects, and 3-Year Posttransplant Outcome

  2019cites this paper
• Cytomegalovirus infection after kidney transplantation and long-term graft loss

  2017cites this paper
• Risk factors for Pneumocystis pneumonia after the first 6 months following renal transplantation

  2017cites this paper
• Title Reinfection of cytomegalovirus in renal transplantation

  2017cites this paper
• Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation

  2017cites this paper
• Long-Term Outcomes and Discard Rate of Kidneys by Decade of Extended Criteria Donor Age.

  2017cites this paper
• Cytomegalovirus infection after kidney transplantation and long-term graft loss.

  2017cites this paper
• Infection du donneur par le CMV et transplantation rénale : impact sur la réponse immunitaire spécifique et sur la survie des greffons

  2017cites this paper
• Cytomegalovirus Infection Associated Neutropenia and Acute Kidney Graft Rejection

  2017cites this paper
• Simultaneous pancreas/kidney transplant recipients are predisposed to tissue‐invasive cytomegalovirus disease and concomitant infectious complications

  2017cites this paper
• Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes

  2016cites this paper
• Fewer cytomegalovirus complications after kidney transplantation by de novo use of mTOR inhibitors in comparison to mycophenolic acid

  2016cites this paper
• The Cell Biology of Cytomegalovirus: Implications for Transplantation

  2016cites this paper
• Organ transplantation related cancer

  2016cites this paper
• Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation

  2015cites this paper
• The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation

  2015cites this paper
• Impact of Cytomegalovirus on Long-term Mortality and Cancer Risk After Organ Transplantation

  2015cites this paper
• The presence of antibodies against the AD2 epitope of cytomegalovirus glycoprotein B is associated with acute rejection after renal transplantation

  2014cites this paper
• Cytomegalovirus Serology and Replication Remain Associated With Solid Organ Graft Rejection and Graft Loss in the Era of Prophylactic Treatment

  2014cites this paper
• Prevalence and risk factors of recurrent cytomegalovirus infection in kidney transplant recipients.

  2014cites this paper
• The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.

  2014cites this paper
• DNA Viral Infections Complicating Lung Transplantation

  2013cites this paper
• Valganciclovir: therapeutic role in pediatric solid organ transplant recipients

  2013cites this paper
• 9 Role of Cytomegalovirus Reinfection in Acute Rejection and CMV Disease After Renal Transplantation

  2012cites this paper
• Role of Cytomegalovirus Reinfection in Acute Rejection and CMV Disease After Renal Transplantation

  2012cites this paper
• Preemptive therapy versus valgancyclovir prophylaxis in cytomegalovirus-positive kidney transplant recipients receiving antithymocyte globulin induction.

  2012cites this paper
• Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies.

  2012influential citation
• Cytomegalovirus Infections in Pediatric Solid Organ Transplant Patients

  2012cites this paper
• Renal Transplantation - Updates and Advances

  2012cites this paper
• [Indirect effects of cytomegalovirus infection].

  2011cites this paper
• Reinfection of cytomegalovirus in renal transplantation.

  2011cites this paper
• Latent cytomegalovirus infection is an independent risk factor for late graft failure in renal transplant recipients

  2011cites this paper
• Epidemiology of Cytomegalovirus Infection After Pancreas Transplantation

  2011cites this paper
• Prolonged Prophylaxis With Valganciclovir Is Cost Effective in Reducing Posttransplant Cytomegalovirus Disease Within the United States

  2010cites this paper
• Cytomegalovirus infection in renal transplant recipients: experience of a Paediatric centre

  2010cites this paper
• Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients

  2010cites this paper
• Anti-Inflammatory Effects of Endothelin Receptor Antagonists and their Importance for Treating Human Disease

  2010cites this paper
• Association of HHV-6 and HHV-7 reactivation with the development of chronic allograft nephropathy.

  2009cites this paper
• Probabilistic Modeling of Cytomegalovirus Infection Under Consensus Clinical Management Guidelines

  2009cites this paper
• Cytomegalovirus infection renal transplant recipients: risk factors and outcome.

  2009cites this paper
• Management of Cytomegalovirus Infection After Renal Transplantation

  2009cites this paper
• Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients.

  2009cites this paper
• CHRONIC LOW-GRADE INFLAMMATION

  2009cites this paper
• Human facial allotransplantation: a 2-year follow-up study.

  2008cites this paper
• Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation.

  2008cites this paper
• Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation

  2008cites this paper
• [Ureterostomy cytomegalovirus infection presenting as stoma ulceration in a kidney allograft receptor: a case report].

  2008cites this paper
• Ureteritis por citomegalovirus en receptor de trasplante renal. Informe de un caso con presentación inusual

  2008cites this paper
• [Cytomegalovirus infection in kidney transplant patients: what is the best way to prevent it?].

  2008cites this paper
• Immunological Monitoring of Calcineurin Inhibitors for Predicting Cytomegalovirus Infection in Kidney Transplant Recipients

  2008cites this paper
• Indirect effects of cytomegalovirus infection in solid organ transplant recipients.

  2008influential citation
• Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study.

  2008cites this paper
• Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.

  2007cites this paper
• Efficacy and safety of preemptive anti‐CMV therapy with valganciclovir after kidney transplantation

  2007cites this paper
• Subclinical cytomegalovirus and Epstein–Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation

  2007cites this paper
• Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.

  2007cites this paper
• Acute hantavirus infection or renal transplant rejection

  2007cites this paper
• The use of consensus guidelines for management of cytomegalovirus infection in renal transplantation.

  2007cites this paper
• Recent developments on endothelin antagonists as immunomodulatory drugs--from infection to transplantation medicine.

  2006cites this paper
• Influence of cytomegalovirus disease on early and late renal graft function.

  2006cites this paper
• Etiology and impact of cytomegalovirus disease on solid organ transplant recipients.

  2006cites this paper
• Acute cytomegalovirus infection complicated by venous thrombosis in a renal transplant recipient.

  2006cites this paper
• The impact of donor cytokine gene polymorphisms on the incidence of cytomegalovirus infection after kidney transplantation.

  2006cites this paper
• Acute Rejection and Cardiac Allograft Vascular Disease Is Reduced by Suppression of Subclinical Cytomegalovirus Infection

  2006cites this paper
• The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.

  2006cites this paper
• Cytomegalovirus in the process of chronic allograft nephropathy

  2006cites this paper
• 24-Week Oral Ganciclovir Prophylaxis in Kidney Recipients Is Associated with Reduced Symptomatic Cytomegalovirus Disease Compared to a 12-Week Course

  2006cites this paper
• CMV‐Specific CD8+ T‐Cell Dynamics in the Blood and the Lung Allograft Reflect Viral Reactivation Following Lung Transplantation

  2006cites this paper
• Signs and symptoms of cytomegalovirus disease in kidney transplant recipients.

  2005cites this paper
• The impact of early cytomegalovirus infection and disease in renal transplant recipients.

  2005cites this paper
• Acute graft pyelonephritis: a potential cause of acute rejection in renal transplant.

  2005cites this paper